SoftBank Robotics Group Makes Strategic Equity Investment in Avalon SteriTech
SoftBank Robotics Group notes upon the completion of the transaction, SBRG will own approximately 5% stake in Avalon’s disinfection business.
Florida / New York
Ph: 561.316.3330
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
SoftBank Robotics Group notes upon the completion of the transaction, SBRG will own approximately 5% stake in Avalon’s disinfection business.
Blue Spark Technologies notes funding will go towards scaling the company’s sales and marketing functions and the continued advancement of Blue Spark’s wearable remote patient monitoring solutions.
David C Dvorak had a successful 16-year career at Zimmer Biomet Holdings, Inc. where he most recently held the position of president and chief executive officer for a decade.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330